S81 Novel Anabolic Approaches to the Treatment of Osteoporosis

Program: Symposia
Clinical Session
Sunday, March 8, 2015: 2:15 PM-3:45 PM
Room 28C (San Diego Convention Center)
**This session is eligible for CME credit**

Henry G Bone, MD, Michigan Bone and Mineral Clinic, Detroit, MI

Disclosure Not Provided: HGB, AD, JAE, SB, RRR

This symposium will bring the audience up to date on promising emerging pharmocotherapies for osteopoorosis.

2:15 PM
Mara J Horwitz, MD, Univ of Pittsburgh, Pittsburgh, PA
Nothing to Disclose: MJH
2:45 PM
Jacques P. Brown, Clinical Professor, Medicine, CHU de Québec (CHUL), Quebec City, QC, Canada
Disclosure: JPB: Advisory Group Member, Amgen, Clinical Researcher, Amgen, Advisory Group Member, Eli Lilly & Company, Clinical Researcher, Eli Lilly & Company, Ad Hoc Consultant, Radius.
3:15 PM
Michael R McClung, MD, FACP, Oregon Osteoporosis Center, Portland, OR
Disclosure: MRM: Advisory Group Member, Amgen, Advisory Group Member, Lilly USA, LLC, Advisory Group Member, Merck & Co., Speaker, Merck & Co., Speaker, Amgen, Scientific Board Member, Merck & Co..
See more of: Symposia
<< Previous Session | Next Session >>